ArticleProtein science : a publication of the Protein Society2025
A large language model for predicting neurotoxic peptides and neurotoxins.
Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- NToxSEM: Enhancing prediction of neurotoxic peptides and neurotoxins using a stacked ensemble-based multimodal framework.Protein science : a publication of the Protein Society · 2026Article
- BiToxNet: a deep learning framework integrating multimodal features for accurate identification of neurotoxic peptides and proteins.BMC biology · 2026Article
- High-Value Transformation of Rice-Derived Bioactive Peptides for Multiscenario Applications: From AI-Aided Design to Molecular Modification.International journal of food science · 2026Review
- A large language model for predicting neurotoxic peptides and neurotoxins.Protein science : a publication of the Protein Society · 2025Article
- Uncovering the potential virulence factors of emerging pathogens using AI/ML-based tools: a case study inFrontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The accurate prediction of neurotoxicity in peptides and proteins is essential for the safety evaluation of therapeutic proteins and genetically modified (GM) organisms. Existing tools, including our earlier method NTxPred, typically use a single predictive model for both neurotoxic peptides and proteins, despite their structural and functional differences. This lack of specialization may lead to suboptimal performance and limited generalizability. To address this, we developed NTxPred2, distinct, specialized models for predicting neurotoxic peptides and neurotoxins (proteins). Our curated datasets include 877 neurotoxic and 877 non-toxic peptides, and 775 neurotoxic and 775 non-toxic proteins. Certain residues, like cysteine, are prevalent in both but in different magnitudes. Using composition and binary profiles, our machine-learning models achieved an area under the curve (AUC) of 0.97 for peptides and 0.85 for proteins, improving to 0.89 with evolutionary information. Models using protein embeddings reached 0.96 AUC for peptides and 0.94 for proteins, while protein language models achieved 0.98 (esm2-t30) and 0.91 (esm2-t6). All models were validated via five-fold cross-validation, and the final models were evaluated on an independent dataset. We further assessed protein models on the peptide dataset and vice versa, highlighting the necessity of separate models. The proposed models outperform existing methods on independent datasets that are not used for training. Our neurotoxicity prediction models will aid in the safety assessment of GM foods and therapeutic proteins by minimizing the need for animal testing. To support the scientific community, we developed a standalone software and web server NTxPred2 for predicting and scanning neurotoxins (https://webs.iiitd.edu.in/raghava/ntxpred2/, https://github.com/raghavagps/ntxpred2/).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.